Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Jill Roberts Center for Inflammatory Bowel Disease
Explore this Website
Home
About Us
Toggle About Us menu options
Clinical Staff
Research Staff
Contact Us
Newsworthy
Toggle Newsworthy menu options
News and Announcements
Patient Care
Toggle Patient Care menu options
Clinical Services
FAQs
For Your Visit
COVID-19 Information
Nutrition Science
Toggle Nutrition Science menu options
Nutrition FAQs
Food Intolerances
News in IBD Nutrition
Research and Clinical Trials
Toggle Research and Clinical Trials menu options
Clinical Trials
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Newsworthy
Patient Care
Nutrition Science
Research and Clinical Trials
Home
Publications
Publications
Clinical Trials
Publications
Publications
Found 238 results
Author
Title
[
Type
]
Year
Filters:
First Letter Of Last Name
is
S
[Clear All Filters]
Journal Article
Lukin DJ
,
Kumar A
,
Hajifathalian K
,
Sharaiha RZ
,
Scherl EJ
,
Longman RS
. 2020.
Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease.
.
Gastroenterology. 159(4):1541-1544.e2.
Battat R
,
Hemperly A
,
Truong S
,
Whitmire N
,
Boland BS
,
Dulai PS
,
Holmer AK
,
Nguyen NH
,
Singh S
,
Casteele NVande
et al.
. 2021.
Baseline Clearance of Infliximab Is Associated With Requirement for Colectomy in Patients With Acute Severe Ulcerative Colitis.
.
Clin Gastroenterol Hepatol. 19(3):511-518.e6.
Battat R
,
Hemperly A
,
Truong S
,
Whitmire N
,
Boland BS
,
Dulai PS
,
Holmer AK
,
Nguyen NH
,
Singh S
,
Casteele NVande
et al.
. 2021.
Baseline Clearance of Infliximab Is Associated With Requirement for Colectomy in Patients With Acute Severe Ulcerative Colitis.
.
Clin Gastroenterol Hepatol. 19(3):511-518.e6.
Persley K
,
Scherl E
,
Rubin P
. 2001.
Avoidance of steroids by the early use of infliximab and 6-mercaptopurine in an adolescent with active Crohn's colitis.
.
Am J Gastroenterol. 96(12):3444-5.
Battat R
,
Kopylov U
,
Bessissow T
,
Bitton A
,
Cohen A
,
Jain A
,
Martel M
,
Seidman E
,
Afif W
. 2017.
Association Between Ustekinumab Trough Concentrations and Clinical, Biomarker, and Endoscopic Outcomes in Patients With Crohn's Disease.
.
Clin Gastroenterol Hepatol. 15(9):1427-1434.e2.
Hassan-Zahraee M
,
Ye Z
,
Xi L
,
Baniecki MLynn
,
Li X
,
Hyde CL
,
Zhang J
,
Raha N
,
Karlsson F
,
Quan J
et al.
. 2021.
Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis.
.
Inflamm Bowel Dis.
Hassan-Zahraee M
,
Ye Z
,
Xi L
,
Baniecki MLynn
,
Li X
,
Hyde CL
,
Zhang J
,
Raha N
,
Karlsson F
,
Quan J
et al.
. 2021.
Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis.
.
Inflamm Bowel Dis.
Verma HDev
,
Scherl EJanice
,
Jacob VElizabeth
,
Bosworth BPaul
. 2011.
Anti-nuclear antibody positivity and the use of certolizumab in inflammatory bowel disease patients who have had arthralgias or lupus-like reactions from infliximab or adalimumab.
.
J Dig Dis. 12(5):379-83.
Battat R
,
Sandborn WJ
. 2021.
Advances in the Comprehensive Management of Postoperative Crohn's Disease.
.
Clin Gastroenterol Hepatol.
Viladomiu M
,
Metz ML
,
Lima SF
,
Jin W-B
,
Chou L
,
Guo C-J
,
Diehl GE
,
Simpson KW
,
Scherl EJ
,
Longman RS
. 2021.
Adherent-invasive E. coli metabolism of propanediol in Crohn's disease regulates phagocytes to drive intestinal inflammation.
.
Cell Host Microbe.
Viladomiu M
,
Metz ML
,
Lima SF
,
Jin W-B
,
Chou L
,
Guo C-J
,
Diehl GE
,
Simpson KW
,
Scherl EJ
,
Longman RS
. 2021.
Adherent-invasive E. coli metabolism of propanediol in Crohn's disease regulates phagocytes to drive intestinal inflammation.
.
Cell Host Microbe.
Zhang S
,
Fu J
,
Dogan B
,
Scherl EJ
,
Simpson KW
. 2018.
5-Aminosalicylic acid downregulates the growth and virulence of Escherichia coli associated with IBD and colorectal cancer, and upregulates host anti-inflammatory activity.
.
J Antibiot (Tokyo). 71(11):950-961.
Zhang S
,
Fu J
,
Dogan B
,
Scherl EJ
,
Simpson KW
. 2018.
5-Aminosalicylic acid downregulates the growth and virulence of Escherichia coli associated with IBD and colorectal cancer, and upregulates host anti-inflammatory activity.
.
J Antibiot (Tokyo). 71(11):950-961.
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
(current)